The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Penile Neoplasms

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Penile Neoplasms

  • FDG uptake was seen in one of the three primary RCCs, in the local recurrence of RCC, in the squamous RCC, and in the metastases of penile cancer [1].

High impact information on Penile Neoplasms


Chemical compound and disease context of Penile Neoplasms


Biological context of Penile Neoplasms


Anatomical context of Penile Neoplasms


Gene context of Penile Neoplasms

  • E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients [14].
  • Human papillomavirus RNA-positive penile cancers were significantly more likely to exhibit adjacent PIN 3 lesions than were HPV-negative tumors, and PIN 3 lesions adjacent to tumors always contained the same HPV-RNA type as was present in the invasive tumor [15].
  • An inverse correlation between HPV and p53 gene mutation is not observed in penile cancers [16].
  • One hundred and fifteen patients with penile cancer were treated at Roswell Park Memorial Institute from 1952 to 1975 [17].

Analytical, diagnostic and therapeutic context of Penile Neoplasms


  1. Uptake of cis-4-[18F]fluoro-L-proline in urologic tumors. Langen, K.J., Börner, A.R., Müller-Mattheis, V., Hamacher, K., Herzog, H., Ackermann, R., Coenen, H.H. J. Nucl. Med. (2001) [Pubmed]
  2. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. Gregoire, L., Cubilla, A.L., Reuter, V.E., Haas, G.P., Lancaster, W.D. J. Natl. Cancer Inst. (1995) [Pubmed]
  3. 18F-FDG PET/CT for staging of penile cancer. Scher, B., Seitz, M., Reiser, M., Hungerhuber, E., Hahn, K., Tiling, R., Herzog, P., Reiser, M., Schneede, P., Dresel, S. J. Nucl. Med. (2005) [Pubmed]
  4. Parathyroid hormone related protein producing penile cancer. Akashi, T., Fuse, H., Muraishi, Y., Mizuno, I., Nagakawa, O., Furuya, Y. J. Urol. (2002) [Pubmed]
  5. Brachytherapy for penile cancer using silicon mold. Akimoto, T., Mitsuhashi, N., Takahashi, I., Yonome, I., Takahashi, M., Hayakawa, K., Niibe, H. Oncology (1997) [Pubmed]
  6. Cisplatin and 5-fluorouracil in advanced cancer of the penis. Shammas, F.V., Ous, S., Fossa, S.D. J. Urol. (1992) [Pubmed]
  7. Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer. Ahmed, T., Sklaroff, R., Yagoda, A. J. Urol. (1984) [Pubmed]
  8. Cancer of the penis. Experience at the Norwegian Radium Hospital 1974-1985. Fosså, S.D., Hall, K.S., Johannessen, N.B., Urnes, T., Kaalhus, O. Eur. Urol. (1987) [Pubmed]
  9. An appraisal of the efficacy of bleomycin in epidermoid carcinoma of the penis. Ahmed, T., Sklaroff, R., Yagoda, A. Anticancer Res. (1984) [Pubmed]
  10. Iridium-192 implantation for node-negative carcinoma of the penis: the Cookridge Hospital experience. Kiltie, A.E., Elwell, C., Close, H.J., Ash, D.V. Clinical oncology (Royal College of Radiologists (Great Britain)) (2000) [Pubmed]
  11. Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Joerger, M., Warzinek, T., Klaeser, B., Kluckert, J.T., Schmid, H.P., Gillessen, S. Urology (2004) [Pubmed]
  12. Chromosome abnormalities in skin fibroblasts probably induced by an anti-cancer drug. Sadamori, N., Honda, T., Toriyama, F. J. Dermatol. (1990) [Pubmed]
  13. Bleomycin effects on malignant tumors of the male genitalia. Rathert, P., Lutzeyer, W. Progress in biochemical pharmacology. (1976) [Pubmed]
  14. E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients. Campos, R.S., Lopes, A., Guimarães, G.C., Carvalho, A.L., Soares, F.A. Urology (2006) [Pubmed]
  15. Differing prevalence of human papillomavirus RNA in penile dysplasias and carcinomas may reflect differing etiologies. Higgins, G.D., Uzelin, D.M., Phillips, G.E., Villa, L.L., Burrell, C.J. Am. J. Clin. Pathol. (1992) [Pubmed]
  16. Expression of p53 and its relationship with human papillomavirus in penile carcinomas. Lam, K.Y., Chan, A.C., Chan, K.W., Leung, M.L., Srivastava, G. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. (1995) [Pubmed]
  17. Surgical treatment of penile cancer: a follow-up report. Wajsman, Z., Moore, R.H., Merrin, C.E., Murphy, G.P. Cancer (1977) [Pubmed]
  18. Cisplatin pasting for radiotherapy of penile cancer. Okuyama, S., Suzuki, Y., Kato, M. Tohoku J. Exp. Med. (1994) [Pubmed]
WikiGenes - Universities